Comparison

APC Anti-Mouse CD8a (2.43) European Partner

Item no. 20-1886-U100
Manufacturer Tonbo Biosciences
Amount 100 ug
Category
Type Antibody Monoclonal
Format APC
Applications FC
Clone 2.43
Specific against Mouse
Host Rat
Isotype IgG2b
Conjugate/Tag APC
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias CD8 alpha, Ly-2, Ly-35, Ly-B, Lyt-2
Similar products 2.43
Available
Description

The 2.43 antibody reacts with the 32-34 kDa alpha subunit of mouse CD8, known as CD8a or CD8 alpha. CD8a can form a homodimer (CD8 alpha-alpha), but is more commonly expressed as a heterodimer with a second chain known as CD8b or CD8 beta. CD8 acts as a co-receptor in antigen recognition and subsequent T cell activation induced by binding of the T cell receptor (TCR) to antigen-bearing MHC Class I molecules. The cytoplasmic domains of CD8 provide binding sites for the tyrosine kinase lck and facilitate intracellular signaling events that lead to T cell activation, development, and cytotoxic effector functions. CD8+ cytotoxic T cells (CTLs) play an important role in inducing cell death in tumor cells, as well as in cells infected by virus, bacteria or parasites.


The 2.43 antibody is widely used as a phenotypic marker for mouse CD8 on cytotoxic T cells, thymocytes, as well as on certain cell types that do not also express the TCR, including some NK cells and lymphoid dendritic cells.


Recent Publications:
Wu J and Waxman DJ. 2015. DOI:10.1080/2162402X.2015.1005521. (Flow Cytometry)


Alternative Names
CD8 alpha, Ly-2, Ly-35, Ly-B, Lyt-2
Gene ID
12525
Citations

Lin J-S, Szaba FM, Kummer LW, Chromy BA, and Smiley ST. 2011. J. Immunol. 187: 897-904. (in vivo depletion)


Wozniak KL, Young ML, and Wormley FL. 2011. Clin. Vaccine Immunol. 18(5):717-723. (in vivo depletion)


Hufford MM, Kim TS, Sun J, and Braciale TJ. 2011. J. Exp. Med. 208: 167-180 (in vivo depletion)


Ou R, zhang M, Huang L, Flavell RA, Koni PA, and Moskophidis D. 2008. J. Virol. 82:2952-2965. (Immunohistochemistry - OCT embedded frozen tissue)


Bosselut R, Zhang W, Ashe JM, Kopacz JL, Samelson LE, and Singer A. 1999. J. Exp. Med. 190: 1517-1526. (in vitro activation)


Davies A, Kalb, S, Liang B, Aldrich CJ, Lemonnier FA, Jiang H, Cotter R, and Soloski MJ. 2003. J. Immunol. 170: 5027-5033. (Blocking)


Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close